Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease

Arie Steinvil1, Ben Sadeh, Yaron Arbel

  • 1Department of Internal Medicine D at Tel-Aviv Sourasky Medical Center, affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. arikst@tasmc.health.gov.il

Insights

The severity of carotid artery stenosis (CAS) correlates with the extent of coronary artery disease (CAD). However, clinically significant CAS prevalence is lower in certain CAD groups than previously thought.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Diagnostic Imaging

Background:

  • Prevalence of combined coronary and carotid atherosclerosis varies due to differing study designs.
  • Understanding this relationship is crucial for comprehensive patient risk assessment.

Purpose of the Study:

  • To evaluate the association between coronary artery disease (CAD) and carotid artery stenosis (CAS).
  • To apply current guidelines for defining CAS.
  • To identify predictors of severe CAS.

Main Methods:

  • Retrospective analysis of prospectively collected data from 1,405 patients undergoing simultaneous coronary angiography and carotid Doppler.
  • Spearman correlations and logistic regression used to analyze data.
  • Carotid artery stenosis defined by peak systolic velocity (PSV).

Main Results:

  • 12.8% had significant CAS (PSV >125 cm/s) and 4.6% had severe CAS (PSV >230 cm/s).
  • Mild CAS was present in 58% of patients.
  • A significant correlation (r=0.255, p<0.001) was found between CAS severity and extent of CAD.
  • Independent predictors of severe CAS included left-main or 3-vessel CAD, age, stroke history, smoking, and diabetes.

Conclusions:

  • The degree of internal carotid artery (ICA) stenosis is linked to the extent of CAD.
  • The prevalence of clinically significant ICA stenosis appears lower in specific CAD subsets than previously reported.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...